| The 2.0 AX‐ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. W Bode, R Engh, D Musil, U Thiele, R Huber, A Karshikov, J Brzin, J Kos, ... The EMBO journal 7 (8), 2593-2599, 1988 | 774 | 1988 |
| Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody P Kocbek, N Obermajer, M Cegnar, J Kos, J Kristl Journal of controlled release 120 (1-2), 18-26, 2007 | 572 | 2007 |
| Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer J Kos, TT Lah Oncology reports 5 (6), 1349-1410, 1998 | 378 | 1998 |
| Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis J Kos, M Krasovec, N Cimerman, HJ Nielsen, IJ Christensen, N Brünner Clinical Cancer Research 6 (2), 505-511, 2000 | 280 | 2000 |
| Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor B Brus, U Kosak, S Turk, A Pislar, N Coquelle, J Kos, J Stojan, JP Colletier, ... Journal of medicinal chemistry 57 (19), 8167-8179, 2014 | 279 | 2014 |
| Lysosomal cathepsins: structure, role in antigen processing and presentation, and cancer V Turk, B Turk, G Gunčar, D Turk, J Kos Advances in enzyme regulation 42, 285-303, 2002 | 268 | 2002 |
| Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients N Cimerman, PM Brguljan, M Krašovec, S Šuškovič, J Kos Clinica chimica acta 300 (1-2), 83-95, 2000 | 264 | 2000 |
| Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients. J Kos, B Stabuc, A Schweiger, M Krasovec, N Cimerman, N Kopitar-Jerala, ... Clinical cancer research: an official journal of the American Association …, 1997 | 259 | 1997 |
| Proteins of higher fungi–from forest to application J Erjavec, J Kos, M Ravnikar, T Dreo, J Sabotič Trends in biotechnology 30 (5), 259-273, 2012 | 246 | 2012 |
| Cysteine proteinases and their inhibitors in extracellular fluids: markers for diagnosis and prognosis in cancer J Kos, B Werle, T Lah, N Brunner The International journal of biological markers 15 (1), 84-89, 2000 | 244 | 2000 |
| Cystatins in immune system Š Magister, J Kos Journal of Cancer 4 (1), 45, 2013 | 243 | 2013 |
| Mechanism of inhibition of papain by chicken egg white cystatin: Inhibition constants of N-terminally truncated forms and cyanogen bromide fragments of the inhibitor W Machleidt, U Thiele, B Laber, I Assfalg-Machleidt, A Esterl, G Wiegand, ... FEBS letters 243 (2), 234-238, 1989 | 229 | 1989 |
| Serum cystatin C, a new marker of glomerular filtration rate, is increased during malignant progression J Kos, B S̆tabuc, N Cimerman, N Brunner Clinical chemistry 44 (12), 2556-2557, 1998 | 214 | 1998 |
| Cysteine cathepsins (proteases)—on the main stage of cancer? V Turk, J Kos, B Turk Cancer cell 5 (5), 409-410, 2004 | 201 | 2004 |
| Microbial and fungal protease inhibitors—current and potential applications J Sabotič, J Kos Applied microbiology and biotechnology 93, 1351-1375, 2012 | 200 | 2012 |
| Intracellular and extracellular cathepsin B facilitate invasion of MCF-10A neoT cells through reconstituted extracellular matrix in vitro A Premzl, V Zavašnik-Bergant, V Turk, J Kos Experimental cell research 283 (2), 206-214, 2003 | 178 | 2003 |
| Prognostic significance of cathepsins B and L in primary human breast cancer. JA Foekens, J Kos, HA Peters, M Krasovec, MP Look, N Cimerman, ... Journal of clinical oncology 16 (3), 1013-1021, 1998 | 178 | 1998 |
| Cysteine proteinases in cancer progression and their clinical relevance for prognosis. TT Lah, J Kos Biological chemistry 379 (2), 125-130, 1998 | 172 | 1998 |
| Regulation of the activity of lysosomal cysteine proteinases by pH-induced inactivation and/or endogenous protein inhibitors, cystatins B Turk, JG Bieth, I Björk, I Dolenc, D Turk, N Cimerman, J Kos, A Čolič, ... Biological chemistry Hoppe-Seyler 376 (4), 225-230, 1995 | 164 | 1995 |
| Purification, characterization and cloning of a ricin B-like lectin from mushroom Clitocybe nebularis with antiproliferative activity against human leukemic T cells J Pohleven, N Obermajer, J Sabotič, S Anžlovar, K Sepčić, J Kos, B Kralj, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1790 (3), 173-181, 2009 | 162 | 2009 |
